Tags

Type your tag names separated by a space and hit enter

Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
Diabetes Technol Ther. 2010 Jun; 12 Suppl 1:S109-14.DT

Abstract

Insulin pump therapy is considered the gold standard for insulin management in patients requiring full physiologic insulin replacement. Compared to traditional delivery of short- and long-acting insulin preparations by multiple daily insulin injections, delivery of insulin via continuous subcutaneous infusion brings with it several advantages, which in the past have translated into better glycemic control and treatment satisfaction. Delivery of insulin via pump reduces the number needle insertions (from four or five per day to once every 2-3 days), allows for greater flexibility of insulin delivery with regard to both the basal and prandial component, facilitates portability of the insulin preparation, and allows for more accurate dosing. Continuous subcutaneous insulin infusion does have some drawbacks, including a greater risk of inadvertent insulin non-delivery, greater costs of therapy, and the need to be "tethered" with some systems that might be considered "burdensome" or even undesirable to some patients. For the most part patients who initiate insulin pump therapy are satisfied and continue using the technology, but there might be instances that arise that require the re-introduction of insulin delivery by pen or syringe. This article will review some of the reasons and strategies for switching from one mode of delivery to the other.

Links

Publisher Full Text

Authors+Show Affiliations

Meneghini L
Division of Endocrinology and Diabetes, University of Miami Miller School of Medicine, 1450 NW 10 Avenue, Miami, FL 33136, USA. lmeneghi@med.miami.edu
Sparrow-Bodenmiller J
No affiliation info available

MeSH

Blood GlucoseDiabetes MellitusHumansHypoglycemic AgentsInjections, SubcutaneousInsulinInsulin Infusion SystemsNeedlesPatient Education as Topic

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20515298

Citation

Meneghini, Luigi, and Jane Sparrow-Bodenmiller. "Practical Aspects and Considerations when Switching Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections." Diabetes Technology & Therapeutics, vol. 12 Suppl 1, 2010, pp. S109-14.
Meneghini L, Sparrow-Bodenmiller J. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. Diabetes Technol Ther. 2010;12 Suppl 1:S109-14.
Meneghini, L., & Sparrow-Bodenmiller, J. (2010). Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. Diabetes Technology & Therapeutics, 12 Suppl 1, S109-14. https://doi.org/10.1089/dia.2009.0184
Meneghini L, Sparrow-Bodenmiller J. Practical Aspects and Considerations when Switching Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections. Diabetes Technol Ther. 2010;12 Suppl 1:S109-14. PubMed PMID: 20515298.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. AU - Meneghini,Luigi, AU - Sparrow-Bodenmiller,Jane, PY - 2010/6/3/entrez PY - 2010/6/11/pubmed PY - 2010/9/16/medline SP - S109 EP - 14 JF - Diabetes technology & therapeutics JO - Diabetes Technol Ther VL - 12 Suppl 1 N2 - Insulin pump therapy is considered the gold standard for insulin management in patients requiring full physiologic insulin replacement. Compared to traditional delivery of short- and long-acting insulin preparations by multiple daily insulin injections, delivery of insulin via continuous subcutaneous infusion brings with it several advantages, which in the past have translated into better glycemic control and treatment satisfaction. Delivery of insulin via pump reduces the number needle insertions (from four or five per day to once every 2-3 days), allows for greater flexibility of insulin delivery with regard to both the basal and prandial component, facilitates portability of the insulin preparation, and allows for more accurate dosing. Continuous subcutaneous insulin infusion does have some drawbacks, including a greater risk of inadvertent insulin non-delivery, greater costs of therapy, and the need to be "tethered" with some systems that might be considered "burdensome" or even undesirable to some patients. For the most part patients who initiate insulin pump therapy are satisfied and continue using the technology, but there might be instances that arise that require the re-introduction of insulin delivery by pen or syringe. This article will review some of the reasons and strategies for switching from one mode of delivery to the other. SN - 1557-8593 UR - https://www.unboundmedicine.com/medline/citation/20515298/Practical_aspects_and_considerations_when_switching_between_continuous_subcutaneous_insulin_infusion_and_multiple_daily_injections_ L2 - https://www.liebertpub.com/doi/10.1089/dia.2009.0184?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -